Burrell Terry-Ann - Insider Non-Derivative Transactions at RECURSION PHARMACEUTICALS, INC. (RXRX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 1, 2024, Burrell Terry-Ann's relationship to RECURSION PHARMACEUTICALS, INC. (RXRX) is Director, and currently has 71,254 shares of Class A Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RXRX insiders.
Data Source: SEC.
Burrell Terry-Ann - Insider Non-Derivative Transactions of RXRX Class A Common Stock
Burrell Terry-Ann - Insider Non-Derivative Transactions at RXRX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 2, 2024 | Acquisition -- (Class A Common Stock) | 1843 | 0 | 71254 |
| Jun 4, 2024 | Acquisition -- (Class A Common Stock) | 13097 | 0 | 69411 |
| Apr 2, 2024 | Acquisition -- (Class A Common Stock) | 1467 | 0 | 56314 |
| Jul 14, 2023 | Sell -- (Class A Common Stock) | 8275 | 12.59 | 54847 |
| Jul 13, 2023 | Sell -- (Class A Common Stock) | 3157 | 14.08 | 63122 |
| Jul 13, 2023 | Sell -- (Class A Common Stock) | 3195 | 13.18 | 66279 |
| Jul 13, 2023 | Sell -- (Class A Common Stock) | 78071 | 12.15 | 69474 |
| Jul 13, 2023 | Sell -- (Class A Common Stock) | 24302 | 11.25 | 147545 |
| Jun 17, 2023 | Acquisition -- (Class A Common Stock) | 12612 | 0 | 171847 |
| Jan 4, 2023 | Acquisition -- (Class A Common Stock) | 1821 | 0 | 159235 |